Ryan P. Werntz

University of Chicago

Papers

1

Total Citations

7

H-Index

1

About

Dr. Ryan P. Werntz is a urologic oncologist whose research centers on advancing minimally invasive surgical techniques for testicular cancer, with a particular focus on robotic retroperitoneal lymph node dissection (RPLND). His major contribution lies in systematically evaluating and refining the indications, evolving technique, and early outcomes of robotic RPLND, a procedure traditionally performed as an open surgery. By demonstrating that robotic approaches can achieve comparable oncologic efficacy with reduced morbidity, Dr. Werntz has helped expand the role of robotic surgery in complex genitourinary oncology. His seminal 2018 paper on this topic, which has garnered 7 citations, serves as a foundational reference for surgeons adopting this technique. Beyond this work, Dr. Werntz has contributed to the broader literature on testicular cancer management, emphasizing the importance of tailoring surgical approaches to patient-specific factors. His research bridges the gap between established open surgical standards and emerging robotic platforms, offering a roadmap for safer, less invasive treatment. For students and researchers, Dr. Werntz’s work exemplifies how careful technique refinement and outcome analysis can drive meaningful change in surgical oncology.

Research Focus

Key Achievements

1
H-Index
1
Papers
7
Total Citations
7
Avg Citations/Paper
🏆 Most Cited Paper
Indications, evolving technique, and early outcomes with robotic retroperitoneal lymph node dissection
7 citations · 2018
📈 Most Prolific Year: 2018 (1 Papers)
🤝 Key Collaborators: 2
🏛 Institutions: University of Chicago

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago